U
NeutriSci International Inc. NUH.V
TSX
Recommendation
Dividend Power Score
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

NeutriSci International Inc. is a Canadian consumer health and wellness company historically focused on nutraceuticals, dietary supplements, and wellness-oriented consumer products. The company has operated primarily in the functional foods and natural health products industry, with a business model centered on product formulation, brand development, and commercialization through retail and direct distribution channels. Public disclosures and historical Canadian securities filings indicate that the company’s activities have included the development and marketing of health-focused ingestible products targeting energy, cognitive support, and general wellness categories.

The company’s principal revenue drivers have historically been consumer wellness products sold under internally developed brands and through strategic distribution relationships. NeutriSci’s positioning has been tied to the broader growth of the global nutraceutical and preventive health market, particularly among consumers seeking non-pharmaceutical wellness products. Historical filings indicate that the company pursued expansion through product innovation, licensing opportunities, and strategic partnerships. Some aspects of the company’s recent operational scale, current commercial activity, and market positioning are difficult to independently verify due to limited recent public disclosure and evolving corporate activity. Data inconclusive based on available public sources.

Business Operations

NeutriSci’s operations have historically centered on the development, branding, and commercialization of nutraceutical products rather than large-scale in-house manufacturing. The company has previously reported activities involving product formulation partnerships, marketing initiatives, and distribution arrangements aimed at the North American health and wellness market. Public filings indicate that the company has relied on outsourced manufacturing and third-party production relationships to support commercialization efforts while maintaining focus on intellectual property, branding, and market expansion.

Historically, NeutriSci’s business activities included operations in both Canada and the United States, with an emphasis on consumer retail distribution and wellness-focused product channels. The company has referenced strategic relationships connected to product development and sales expansion, although the scale and continuity of several partnerships have varied over time. Publicly available information does not consistently identify major long-term subsidiaries or material joint ventures currently contributing significant recurring revenue. Data inconclusive based on available public sources.

Strategic Position & Investments

NeutriSci’s historical strategy has focused on participation in the growing preventive health and nutraceutical sectors through branded consumer products and wellness innovation. The company has previously pursued growth initiatives tied to product launches, retail channel expansion, and licensing opportunities. Public filings and investor materials have also reflected efforts to capitalize on consumer demand for functional health products positioned around convenience and lifestyle-oriented wellness trends.

The company’s strategic direction has evolved over time alongside broader market conditions in the micro-cap health and wellness sector. Historical disclosures indicate periodic evaluation of acquisitions, financing initiatives, and corporate restructuring opportunities intended to support growth and operational continuity. However, publicly verifiable information regarding significant recent acquisitions, material portfolio investments, or large-scale ownership stakes in emerging technology businesses remains limited. Data inconclusive based on available public sources.

Geographic Footprint

NeutriSci International Inc. has been headquartered in Canada, with historical operational and commercial activities extending into the United States. The company’s market focus has primarily been concentrated in North America, particularly within consumer wellness and nutraceutical distribution channels. Public disclosures indicate that the company sought broader international visibility through publicly traded market access and product commercialization initiatives.

While the company has referenced opportunities for international growth and broader distribution, independently verified evidence of large-scale operational infrastructure outside North America is limited. Available filings and disclosures do not indicate a substantial multinational manufacturing or logistics footprint comparable to larger global wellness companies. Data inconclusive based on available public sources.

Leadership & Governance

NeutriSci International Inc. has historically operated under a conventional public-company governance structure consisting of executive leadership and a board of directors overseeing strategic and operational decisions. Leadership direction has generally emphasized commercialization of wellness-oriented consumer products, capital market access, and expansion within the nutraceutical sector. Due to changes in management over time and limited recent disclosures, some executive role information may not be consistently current across all public records.

Key executives and directors identified in historical public filings and corporate disclosures include:

  • Glen Rehman – Chief Executive Officer
  • Paul Dosanjh – Former executive leadership and founder-related role associated with early company development
  • Board of Directors and executive leadership positions – Various appointments disclosed periodically through Canadian securities filings

Recent confirmation of the complete current executive team and governance structure is limited in publicly accessible materials. Data inconclusive based on available public sources.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $217.50
B
AAPL NASDAQ $304.91
B
AVGO NASDAQ $416.08
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $113.26
Top Financial Stocks
See All »
B
B
JPM NYSE $362.04
B
V NYSE $362.82
Top Energy Stocks
See All »
B
ENB NYSE $51.57
B
ENB.TO TSX $71.55
Top Health Care Stocks
See All »
B
LLY NYSE $1,215.02
B
JNJ NYSE $259.80
B
ABBV NYSE $250.09
Top Real Estate Stocks
See All »
B
PLD NYSE $139.50
B
EQIX NASDAQ $1,032.40